JOHNSON & JOHNSON — Director's Dealing 2025

May 5, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: JOHNSON & JOHNSON (JNJ)
CIK: 0000200406
Period of Report: 2025-05-01

Reporting Person: REED JOHN C (EVP, Innovative Medicine, R&D)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-05-01	Common Stock	M	25255	—	Acquired	40797	Direct
2025-05-01	Common Stock	F	11002	$156.31	Disposed	29795	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-05-01	Restricted Share Units	$	M	25255	Disposed		Common Stock (25255)	Direct

Footnotes

F1: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on May 1, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting.

F2: Shares withheld for payment of taxes upon vesting of RSUs.